Establishment Labs Cash Flow Statement
NASDAQ: ESTAHealth CareIndustrial SpecialtiesUSD
61.67+1.06 (+1.75%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Establishment Labs free cash flow
In fiscal 2025, Establishment Labs generated -$50.9 million of operating cash flow and spent $6.0 million on capital expenditures. That left free cash flow of -$56.9 million, a free-cash-flow margin of -27.0% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Establishment Labs cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -51.06M | -84.60M | -78.50M | -75.21M | -41.14M | -38.12M | -38.15M | -21.10M | -34.90M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 6.20M | 4.70M | 2.80M | 2.50M | 2.50M | — | — | — | — |
| Stock-Based Compensation | 11.41M | 14.40M | 14.36M | 13.36M | 10.41M | 5.72M | 6.53M | 7.32M | — |
| Change in Working Capital | -14.59M | -18.77M | -32.10M | -23.23M | -10.85M | 10.07M | -9.19M | -17.78M | -14.86M |
| Operating Cash Flow | -50.89M | -58.52M | -88.51M | -52.17M | -27.53M | -12.51M | -29.98M | -33.88M | -31.97M |
| Capital Expenditures | -6.05M | -6.11M | -7.91M | -2.85M | -2.42M | -2.11M | -6.29M | -1.73M | -901.00K |
| Investing Cash Flow | -7.03M | -15.61M | -24.55M | -34.79M | -7.16M | -5.56M | -7.77M | -5.73M | -845.00K |
| Share Repurchases | — | — | — | — | — | — | — | 0 | -4.51M |
| Financing Cash Flow | 40.43M | 125.89M | 86.23M | 100.25M | 4.05M | 64.67M | 22.79M | 81.53M | 42.99M |
| Net Change in Cash | -14.78M | 50.31M | -26.32M | 12.94M | -31.11M | 46.87M | -14.98M | 41.77M | 10.38M |
| Free Cash Flow | -56.94M | -64.63M | -96.42M | -55.02M | -29.96M | -14.62M | -36.27M | -35.62M | -32.87M |
This table shows 9 annual periods of Establishment Labs's cash flow statement, from FY 2025 back to FY 2017, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ESTA's reporting calendar. What is a cash flow statement?